TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003.

Arkadiusz Z Dudek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.